ALDOCK
ALDOCK offers a risk test that identifies individuals at higher likelihood of having early-stage cancer to enable earlier clinical follow-up. The company analyzes biomarker measurement results with machine learning and maintains an NGS analysis pipeline to improve test accuracy. It operates as a healthcare technology provider, offering a secure API and SDK for integration with clinical applications and allowing users to view inspection results via companion apps. ALDOCK is positioned for use by diagnostic labs, healthcare providers, and digital health platforms focused on cancer screening and early detection.
ALDOCK
ALDOCK offers a risk test that identifies individuals at higher likelihood of having early-stage cancer to enable earlier clinical follow-up. The company analyzes biomarker measurement results with machine learning and maintains an NGS analysis pipeline to improve test accuracy. It operates as a healthcare technology provider, offering a secure API and SDK for integration with clinical applications and allowing users to view inspection results via companion apps. ALDOCK is positioned for use by diagnostic labs, healthcare providers, and digital health platforms focused on cancer screening and early detection.